House GOP blocks Trump-supported drug pricing provision from spending bill

House GOP blocks Trump-supported drug pricing provision from spending bill
© Getty

House Republicans on Thursday blocked a drug pricing amendment supported by President TrumpDonald John TrumpTrump administration eyes proposal to block jet engine sales to China: report Trump takes track to open Daytona 500 Brazile 'extremely dismayed' by Bloomberg record MORE from inclusion in a health-care spending bill.

The provision, which passed the Senate on a bipartisan basis last month, would require drug prices to be disclosed in television advertisements for drugs in an effort to increase transparency and bring down prices.

Lawmakers and aides said that House Republicans objected to including the provision in the final version of the funding bill, which was finished by House and Senate negotiators on Thursday.

ADVERTISEMENT

Sen. Dick DurbinRichard (Dick) Joseph DurbinThe Hill's Morning Report — AG Barr, GOP senators try to rein Trump in The Hill's Morning Report - Sanders surge triggers Dem angst As many as eight GOP senators expected to vote to curb Trump's power to attack Iran MORE (D-Ill.), one of the sponsors of the provision, blamed pharmaceutical companies for exercising their influence to block the measure.

“When are we going to stand up to Big Pharma?” Durbin asked.

He noted that Trump supported the measure, reading aloud a tweet from the president last month praising the measure as a move “to end the secrecy around ridiculously high drug prices.” The proposal is part of Trump’s plan to lower drug prices, something the president has been vocal about.

Republican Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyOvernight Health Care: Nevada union won't endorse before caucuses after 'Medicare for All' scrap | McConnell tees up votes on two abortion bills | CDC confirms 15th US coronavirus case Mnuchin defends Treasury regulations on GOP tax law Wyden, Mnuchin clash over Trump tax returns, Hunter Biden probe MORE (Iowa), who co-sponsored the measure with Durbin, tweeted Thursday that it is “EMBARRASSING to bow to BIG PHARMA at expense of consumers” and not include the provision.

Asked about the objections, Rep. Tom ColeThomas (Tom) Jeffrey ColeTrump's best week ever? McCarthy raises over million in Q4 for House GOP GOP leader warns lawmakers on fundraising: 'Getting our ass kicked' MORE (R-Okla.), the top health appropriator in the House, said he did not want to get into the details, but said that some House Republicans opposed the provision.

ADVERTISEMENT

“Our friends in the House felt differently on this topic,” said Sen. Roy BluntRoy Dean BluntBooker, Merkley propose federal facial recognition moratorium GOP senators defend Sondland, Vindman ousters: They weren't 'loyal' McConnell displays mastery of Senate with impeachment victory MORE (R-Mo.), the top Senate health appropriator.

After failing to get the provision into the underlying funding bill on Thursday, Durbin offered it as an amendment before withdrawing it after other lawmakers said they did not want to jeopardize passage of the larger health funding bill by voting on the amendment.

A spokeswoman for House Energy and Commerce Committee Chairman Greg WaldenGregory (Greg) Paul WaldenGOP climate plan faces pushback — from Republicans Coalition plan seeks to cut carbon emissions in half by 2035 Overnight Energy: Panel gives chairman power to subpoena Interior | House passes bill to protect wilderness | House Republicans propose carbon capture bill | Ocasio-Cortez introduces bill to ban fracking MORE (R-Ore.), whose committee oversees drug pricing issues, said that he did not oppose the provision.